Healthcare Industry News: M. D. Anderson Cancer Center
News Release - July 25, 2006
IMPAC Announces Clinical Support for Proton Therapy at M. D. Anderson Cancer CenterMulti-Vendor, Multi-Disciplinary Team Reaches Major Milestone to Advance Radiation Therapy Treatment Management
MOUNTAIN VIEW, Calif., July 25 (HSMN NewsFeed) -- IMPAC Medical Systems, Inc. (IMPAC), an Elekta Company and a leading provider of information technology solutions for oncology care, announces that since May 2006, The University of Texas M. D. Anderson Cancer Center has been in clinical use with IMPAC's treatment management solution to manage delivery and chart radiation therapy treatments at its new proton therapy center.
"The clinical implementation of EMR support for proton therapy represents years of collaborative design and development between M. D. Anderson Cancer Center and IMPAC," stated Annette Coleman, IMPAC's product manager for multi-modality, image enabled charting. Coleman added that while the project focused primarily on EMR support for proton therapy, customers using more conventional treatment methods will benefit from the work done on this project. "Many new and exciting features developed for proton therapy will soon be incorporated into the conventional treatment environment within MOSAIQ(TM), including fundamental enhancements and added efficiencies to the treatment delivery process."
"The proton therapy center was among the many innovative patient care projects undertaken by M. D. Anderson Cancer Center, resulting from the sum total of the hard work of a multi-disciplinary team including radiation oncologists, physicists, information services professionals and senior leadership," stated James D. Cox, MD, Professor and Head, Division of Radiation Oncology. "Moreover, the shared vision and effort of a group of vendors including IMPAC made the process manageable and the outcome a reality. IMPAC integrated proton support into our existing IT implementation, allowing us to extend our current chartless radiation therapy environment to the new proton center."
"IMPAC continues its mission to provide the best oncology information management system to support any combination of treatment planning and delivery equipment our customers may choose," stated Jay Hoey, President and CEO of IMPAC. "The development efforts devoted to the proton center further demonstrate our dedication to providing leading-edge clinical capabilities in multi-manufacturer environments, empowering customers to pursue best-of-breed solutions. Our worldwide installed base of oncology EMRs, which integrates with planning systems and treatment devices from multiple manufacturers, demonstrates how we leverage our experience to provide comprehensive management of advanced radiation therapy treatments."
The multi-vendor team that collaborated with IMPAC to meet M. D. Anderson's specific clinical requirements included Hitachi, Ltd. and Varian Medical Systems.
For more information, please contact:
Lorna Murdock, Marketing Communications Manager
IMPAC Medical Systems, Inc.
Tel: +1-650-623-8937, e-mail: email@example.com
IMPAC Medical Systems, Inc.
Tel: 760-743-2899, e-mail: firstname.lastname@example.org
Peter Ejemyr, Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000, e-mail: email@example.com
About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc., an Elekta company, provides healthcare information technology (IT) solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC's open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory, and cancer registry. With products that are used in association with diagnosis and treatment environments through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency, and the quality of patient care. For more information about IMPAC products and services, please call 888-GO-IMPAC or visit www.impac.com.
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective. Clinical solutions include among others Leksell Gamma Knife® for non- invasive treatment of brain disorders and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world's largest supplier of oncology software. Elekta's systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders. With approx. 1,850 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
Source: IMPAC Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.